The antitumor agent doxorubicin binds to Fanconi anemia group F protein-Reference-Cited by-同舟云学术

The antitumor agent doxorubicin binds to Fanconi anemia group F protein

Published:2012-11 Issue:21 Volume:20 Page:6248-6255
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Kusayanagi Tomoe,Tsukuda Senko,Shimura Satomi,Manita Daisuke,Iwakiri Kanako,Kamisuki Shinji,Takakusagi Yoichi,Takeuchi Toshifumi,Kuramochi Kouji,Nakazaki Atsuo,Sakaguchi Kengo,Kobayashi Susumu,Sugawara Fumio

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference37 articles.

1. New Chemotherapeutic Agents... Bleomycin and Adriamycin

2. Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin

3. Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group study

4. Adriamycin in combination for the treatment of breast cancer.A southwest oncology group study

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent trends in T7 phage application in diagnosis and treatment of various diseases;International Immunopharmacology;2022-09

2. Association of variations in the Fanconi anemia complementation group and prognosis in Non–small cell lung cancer patients with Platinum-based chemotherapy;Gene;2022-05

3. A comprehensive screening method for investigating the potential binding targets of doxorubicin based on protein microarray;European Journal of Pharmacology;2021-04

4. Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions;Journal of Visualized Experiments;2020-12-01

5. Phage display technology for target determination of small-molecule therapeutics: an update;Expert Opinion on Drug Discovery;2020-07-13